Open AccessLetter by Martin et al Regarding Article, “Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial”
Author(s) -
AnneCéline Martin,
Éloi Marijon,
Kumar Narayanan
Publication year - 2019
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.118.037019
Subject(s) - medicine , edoxaban , pharmacodynamics , timi , pharmacology , endogeny , clinical trial , pharmacokinetics , rivaroxaban , warfarin , myocardial infarction , thrombolysis , atrial fibrillation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom